Cargando…

Oxidative stress enhances the immune response to oxidatively modified catalase enzyme in patients with Graves’ disease

BACKGROUND: Oxidative stress is associated with several autoimmune disorders and oxidative modification of proteins that may result in autoimmune response. This study aims to evaluate the catalase (CAT) activity and the autoimmune response against the native CAT and the oxidatively modified enzyme i...

Descripción completa

Detalles Bibliográficos
Autores principales: Gargouri, Bochra, Mseddi, Malek, Mnif, Fatma, Abid, Mohamed, Attia, Hamadi, Lassoued, Saloua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7031633/
https://www.ncbi.nlm.nih.gov/pubmed/31617239
http://dx.doi.org/10.1002/jcla.23051
_version_ 1783499417250168832
author Gargouri, Bochra
Mseddi, Malek
Mnif, Fatma
Abid, Mohamed
Attia, Hamadi
Lassoued, Saloua
author_facet Gargouri, Bochra
Mseddi, Malek
Mnif, Fatma
Abid, Mohamed
Attia, Hamadi
Lassoued, Saloua
author_sort Gargouri, Bochra
collection PubMed
description BACKGROUND: Oxidative stress is associated with several autoimmune disorders and oxidative modification of proteins that may result in autoimmune response. This study aims to evaluate the catalase (CAT) activity and the autoimmune response against the native CAT and the oxidatively modified enzyme in patients with Graves' disease (GD) and healthy controls in a comparative way. METHODS: The CAT activity was evaluated via spectrophotometric method. Using enzyme‐linked immunosorbent assay, the reactivities of autoantibody toward native, malondialdehyde (MDA) and hydrogen peroxide (H(2)O(2)) modified CAT were evaluated in plasmas of patients and controls. RESULTS: Reduced CAT activity was found in patients compared with controls (P < .05). It was proved that levels of IgG antibodies against MDA‐modified CAT were higher than against unmodified ones (P < .001). No changes were found for the reactivities to H(2)O(2)‐modified CAT. Positive correlation was found between the reactivity to MDA‐modified CAT and the triiodothyronine level (P < .001, r = .6). CONCLUSION: Our findings incriminate the MDA in the autoantibodies reactivity to oxidatively modified CAT leading to a disturbed oxidative profile and/or the progression of GD pathology.
format Online
Article
Text
id pubmed-7031633
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-70316332020-02-27 Oxidative stress enhances the immune response to oxidatively modified catalase enzyme in patients with Graves’ disease Gargouri, Bochra Mseddi, Malek Mnif, Fatma Abid, Mohamed Attia, Hamadi Lassoued, Saloua J Clin Lab Anal Research Articles BACKGROUND: Oxidative stress is associated with several autoimmune disorders and oxidative modification of proteins that may result in autoimmune response. This study aims to evaluate the catalase (CAT) activity and the autoimmune response against the native CAT and the oxidatively modified enzyme in patients with Graves' disease (GD) and healthy controls in a comparative way. METHODS: The CAT activity was evaluated via spectrophotometric method. Using enzyme‐linked immunosorbent assay, the reactivities of autoantibody toward native, malondialdehyde (MDA) and hydrogen peroxide (H(2)O(2)) modified CAT were evaluated in plasmas of patients and controls. RESULTS: Reduced CAT activity was found in patients compared with controls (P < .05). It was proved that levels of IgG antibodies against MDA‐modified CAT were higher than against unmodified ones (P < .001). No changes were found for the reactivities to H(2)O(2)‐modified CAT. Positive correlation was found between the reactivity to MDA‐modified CAT and the triiodothyronine level (P < .001, r = .6). CONCLUSION: Our findings incriminate the MDA in the autoantibodies reactivity to oxidatively modified CAT leading to a disturbed oxidative profile and/or the progression of GD pathology. John Wiley and Sons Inc. 2019-10-16 /pmc/articles/PMC7031633/ /pubmed/31617239 http://dx.doi.org/10.1002/jcla.23051 Text en © 2019 The Authors. Journal of Clinical Laboratory Analysis published by Wiley Periodicals, Inc. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Articles
Gargouri, Bochra
Mseddi, Malek
Mnif, Fatma
Abid, Mohamed
Attia, Hamadi
Lassoued, Saloua
Oxidative stress enhances the immune response to oxidatively modified catalase enzyme in patients with Graves’ disease
title Oxidative stress enhances the immune response to oxidatively modified catalase enzyme in patients with Graves’ disease
title_full Oxidative stress enhances the immune response to oxidatively modified catalase enzyme in patients with Graves’ disease
title_fullStr Oxidative stress enhances the immune response to oxidatively modified catalase enzyme in patients with Graves’ disease
title_full_unstemmed Oxidative stress enhances the immune response to oxidatively modified catalase enzyme in patients with Graves’ disease
title_short Oxidative stress enhances the immune response to oxidatively modified catalase enzyme in patients with Graves’ disease
title_sort oxidative stress enhances the immune response to oxidatively modified catalase enzyme in patients with graves’ disease
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7031633/
https://www.ncbi.nlm.nih.gov/pubmed/31617239
http://dx.doi.org/10.1002/jcla.23051
work_keys_str_mv AT gargouribochra oxidativestressenhancestheimmuneresponsetooxidativelymodifiedcatalaseenzymeinpatientswithgravesdisease
AT mseddimalek oxidativestressenhancestheimmuneresponsetooxidativelymodifiedcatalaseenzymeinpatientswithgravesdisease
AT mniffatma oxidativestressenhancestheimmuneresponsetooxidativelymodifiedcatalaseenzymeinpatientswithgravesdisease
AT abidmohamed oxidativestressenhancestheimmuneresponsetooxidativelymodifiedcatalaseenzymeinpatientswithgravesdisease
AT attiahamadi oxidativestressenhancestheimmuneresponsetooxidativelymodifiedcatalaseenzymeinpatientswithgravesdisease
AT lassouedsaloua oxidativestressenhancestheimmuneresponsetooxidativelymodifiedcatalaseenzymeinpatientswithgravesdisease